Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ANI Pharmaceuticals, Inc. (ANIP) had Weighted-Average Shares Outstanding (Diluted) of 20.05M for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
$197.12M |
|
$15.28M |
|
$73.04M |
|
$124.08M |
|
$170.93M |
|
$26.19M |
|
$-6.21M |
|
$19.99M |
|
$19.99M |
|
$15.68M |
|
$15.68M |
|
$15.68M |
|
$15.68M |
|
$26.19M |
|
$49.09M |
|
19.61M |
|
Weighted-Average Shares Outstanding (Diluted) |
20.05M |
$0.70 |
|
$0.69 |
|
Balance Sheet Financials | |
$536.29M |
|
$58.18M |
|
$756.14M |
|
$1.29B |
|
$201.81M |
|
$611.63M |
|
$647.14M |
|
$848.96M |
|
$418.62M |
|
$-155.69M |
|
$443.47M |
|
21.67M |
|
Cash Flow Statement Financials | |
$34.99M |
|
$-19.85M |
|
$-9.91M |
|
$144.89M |
|
$149.84M |
|
$4.94M |
|
$8.87M |
|
-- |
|
$-0.41M |
|
Fundamental Metrics & Ratios | |
2.66 |
|
-- |
|
-- |
|
0.58 |
|
1.40 |
|
62.95% |
|
13.29% |
|
13.29% |
|
-- |
|
10.14% |
|
7.75% |
|
$32.52M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.53 |
|
0.89 |
|
100.60 |
|
3.75% |
|
-10.07% |
|
1.21% |
|
1.49% |
|
$20.46 |
|
$1.62 |
|
$1.75 |